Plain-English translation of NCT06987565 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing transcutaneous vagus nerve stimulation (taVNS)—a gentle, non-invasive treatment that stimulates the vagus nerve through the skin—to see if it can reduce muscle and joint pain and fatigue in people with systemic lupus erythematosus (SLE). A smaller earlier study showed very promising results, and this new trial will test whether longer treatment (28 days instead of 4 days) works even better and lasts longer after stopping. About half of participants will receive the real treatment, and half will receive a sham (fake) treatment to fairly measure how well this medication works.
Muscle and joint pain and fatigue affect up to 95% of lupus patients and significantly hurt their quality of life, yet safe and effective treatments for these symptoms are limited. This trial explores whether stimulating the vagus nerve could offer a new, gentle way to help control these difficult symptoms.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive either real or sham vagus nerve stimulation—a quick, painless procedure performed for just 5 minutes each day for 28 consecutive days. You'll then stop treatment and be monitored for another 28 days to see how long any benefits last. Throughout the trial, researchers will measure your pain, fatigue, and disease activity, and they may collect blood samples and other information to understand how the treatment works.
AI-generated summary from trial data · Sep 20, 2026 · Not medical advice
United States